News Sentiment

MDCX sentiment intelligence

Medicus Pharma Ltd. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 53 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 0.41 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-2.1% over one week, +20.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Medicus Pharma redesigns Phase 2 trial for 126 patients

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -2.1% Price reacting lower
Trend fit Trend inactive 20.7% over four weeks
Fair value -81.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 32
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Proactive 4
Stock Titan 4
GlobeNewswire 3
Market source 3
MT Newswires 2
ad-hoc-news.de 2
Finviz 2
AskTraders 2

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 7
Guidance 3
Regulatory and legal 2
Analyst action 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40